Italy - English - HMA (Heads of Medicines Agencies)

merial - infectious bronchitis virus 3.7 log10 eid50 - aqueous suspension - chicken - avian infectious bronchitis virus vaccine

Netherlands - English - HMA (Heads of Medicines Agencies)

merial - infectious bronchitis virus 3.7 log10 eid50 - aqueous suspension - chicken - avian infectious bronchitis virus vaccine

Romania - English - HMA (Heads of Medicines Agencies)

merial - infectious bronchitis virus 3.7 log10 eid50 - aqueous suspension - chicken - avian infectious bronchitis virus vaccine

Slovenia - English - HMA (Heads of Medicines Agencies)

merial - infectious bronchitis virus 3.7 log10 eid50 - aqueous suspension - chicken - avian infectious bronchitis virus vaccine

United Kingdom - English - HMA (Heads of Medicines Agencies)

merial - infectious bronchitis virus 3.7 log10 eid50 - aqueous suspension - chicken - avian infectious bronchitis virus vaccine

United States - English - NLM (National Library of Medicine)

boehringer ingelheim animal health usa inc. - cephapirin sodium (unii: 431lff7i7j) (cephapirin - unii:89b59h32vn) - cephapirin 200 mg in 10 ml - for lactating cows only / for the treatment of bovine mastitis today (cephapirin sodium) for intramammary infusion should be used at the first signs of inflammation or at the first indication of any alteration in the milk. treatment is indicated immediately upon determining, by c.m.t. or other tests, that the leukocyte count is elevated, or that a susceptible pathogen has been cultured from the milk. today for intramammary infusion has been shown to be efficacious in the treatment of mastitis in lactating cows caused by susceptible strains of streptococcus agalactiae and staphylococcus aureus including strains resistant to penicillin. indicaciones Únicamente para vacas lactantes / para el tratamiento de mastitis bovina today (cefapirina sódica) para infusión intramamaria deberá administrarse desde los primeros signos de inflamación o al primer indicio de cualquier alteración de la leche. el tratamiento resulta indicado inmediatamente después de determinar mediante la prueba de california para mastitis (c.m.

European Union - English - EMA (European Medicines Agency)

zentiva k.s. - efavirenz, emtricitabine, tenofovir disoproxil, phosphate - hiv infections - antivirals for systemic use, - efavirenz/emtricitabine/tenofovir disoproxil zentiva is a fixed-dose combination of efavirenz, emtricitabine and tenofovir disoproxil. it is indicated for the treatment of human immunodeficiency virus-1 (hiv-1) infection in adults aged 18 years and over with virologic suppression to hiv-1 rna levels of < 50 copies/ml on their current combination antiretroviral therapy for more than three months. patients must not have experienced virological failure on any prior antiretroviral therapy and must be known not to have harboured virus strains with mutations conferring significant resistance to any of the three components contained in efavirenz/emtricitabine/tenofovir disoproxil zentiva prior to initiation of their first antiretroviral treatment regimen., the demonstration of the benefit of the combination efavirenz/emtricitabine/tenofovir disoproxil is primarily based on 48-week data from a clinical study in which patients with stable virologic suppression on a combination antiretroviral therapy changed to efavir

Germany - English - HMA (Heads of Medicines Agencies)

ceva santé animale - infectious bronchitis virus 2.8 eid50/dose - oral lyophilisate - chicken broilers, chicken layers - immunologicals

Ireland - English - HMA (Heads of Medicines Agencies)

ceva santé animale - infectious bronchitis virus 2.8 eid50/dose - oral lyophilisate - chicken broilers, chicken layers - immunologicals

Hungary - English - HMA (Heads of Medicines Agencies)

ceva santé animale - infectious bronchitis virus 2.8 eid50/dose - oral lyophilisate - chicken broilers, chicken layers - immunologicals